Overview
Dual GIP and GLP-1 receptor agonist. Amplifies insulin response, blunts appetite, drives fat loss with stronger glycemic control than semaglutide alone. Provided for research/laboratory reference.
Reported Dosing Ranges
Reference information only. Not medical advice, prescriptions, or recommendations.
Fat Loss / Glycemic Support (research reference)
Dosage
1.25-5.0 mg
Frequency
Twice weekly (e.g., Mon/Thu or Tue/Fri)
Cycle Length
12 weeks
Timing
AM or mid-day on injection days
Notes
Subcutaneous abdomen or thigh. Stepped dose: 1.25 mg 2x/wk for 4 wks → 2.5 mg 2x/wk for 4 wks → 5.0 mg 2x/wk for final 4 wks. Approved consumer products (Mounjaro, Zepbound) require a prescription.
Reconstitution Calculator
* U-30 recommended for this dose (12.5 units)
Your Dose
Draw to
12.5units
(0.125 mL) on a U-100 syringe
Syringe Fill
U-100 insulin syringe
Reconstitution
Concentration
10.00 mg/mL
mcg per mL
10000 mcg
Per Unit (IU)
100.0 mcg
Doses Per Vial
8 doses
Storage
🌡️ Refrigerate at 2-8°C
📋 Stable ~30 days reconstituted.
⏱️ Shelf life: 30 days after reconstitution